Charles + Colvard Ltd. buy krebskrebs
Start price
03.05.22
/
50%
€1.29
Target price
03.05.23
€1.80
Performance (%)
-33.33%
End price
04.05.23
€0.86
Summary
This prediction ended on 04.05.23 with a price of €0.86. Massive losses of -33.33% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Charles + Colvard Ltd. | - | - | - | - |
| iShares Core DAX® | -3,64 % | -8,78 % | -0,69 % | 49,50 % |
| iShares Nasdaq 100 | -2,99 % | -1,71 % | 11,95 % | 76,92 % |
| iShares Nikkei 225® | -3,00 % | -9,10 % | 23,39 % | 48,52 % |
| iShares S&P 500 | -2,39 % | -2,78 % | 7,62 % | 58,90 % |
Comments by krebskrebs for this prediction
In the thread Charles + Colvard Ltd. diskutieren
In the thread Trading Charles + Colvard Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten